| 2006-06-15 |
Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies |
Journal of Medicinal Chemistry. 2006 Jun;49(12):3485-3495. |
 |
| 2006-06-15 |
Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors |
Bioorganic and Medicinal Chemistry Letters. 2006 Jun;16(12):3268-3272. |
|
| 2006-05-04 |
Structure-based drug design of a novel family of PPAR gamma partial agonists: Virtual screening, X-ray crystallography, and in vitro/in vivo biological activities |
Journal of Medicinal Chemistry. 2006 May;49(9):2703-2712. |
|
| 2006-05 |
Antitubulin agents for the treatment of cancer - a medicinal chemistry update |
Expert Opinion on Therapeutic Patents. 2006 May;16(5):647-691. |
|
| 2006-02-09 |
Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: Design, synthesis, structural biology, and molecular docking studies |
Journal of Medicinal Chemistry. 2006 Feb;49(3):1212-1216. |
|
| 2006-01-12 |
2-[3-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,2,3,4-tetrahydroisoquinoline: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV |
Journal of Medicinal Chemistry. 2006 Jan;49(1):373-380. |
|
| 2006-01-01 |
Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system |
Bioorganic and Medicinal Chemistry. 2006 Jan 1;14(1):83-91. |
|
| 2005-12-29 |
Novel indole-based peroxisome proliferator-activated receptor agonists: Design, SAR, structural biology, and biological activities |
Journal of Medicinal Chemistry. 2005 Dec;48(26):8194-8208. |
|
| 2005-08-23 |
Indole compounds |
US6933316B2/2005-08-23 |
|
| 2005-05 |
Shear stress inhibits smooth muscle cell-induced inflammatory gene expression in endothelial cells - Role of NF-kappa B |
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005 May;25(5):963-969. |
|
| 2005-05 |
Pharmaceutical design of antimitotic agents based on combretastatins |
Current Pharmaceutical Design. 2005 May;11(13):1655-1677. |
|
| 2005-03 |
Promazine analogues as potential anti SARS-CoV drugs |
Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U168. |
|
| 2005-03 |
Design, synthesis and sar of indole-based PPAR agonists |
Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U141. |
|
| 2005-03 |
Design and structure-activity relationships of novel indole-based PPAR agonists as antidiabetic agents |
Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U141. |
|
| 2005 |
Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3 '- digallate (TF3) |
Evidence-based Complementary and Alternative Medicine. 2005;2:209-215. |
|
| 2004-09-10 |
Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV |
FEBS Letters. 2004 Sep;574(1-3):116-120. |
|
| 2004-09 |
Drug design of BPR0L075 as an anticancer agent |
World Conference on Magic Bullets - Celebrating Paul Ehrlich's 150th Birthday. 2004 Sep 9-11:Abstract # 203. |
|
| 2004-08-22 |
Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents |
Abstracts of Papers - American Chemical Society. 2004 Aug 22;228:U924. |
|
| 2004-08-12 |
Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents |
Journal of Medicinal Chemistry. 2004 Aug;47(17):4247-4257. |
|
| 2004-07-15 |
A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells |
Biochemical Pharmacology. 2004 Jul;68(2):293-303. |
|
| 2004-07-01 |
BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo |
Cancer Research. 2004 Jul;64(13):4621-4628. |
|
| 2004-07 |
Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide |
Antimicrobial Agents and Chemotherapy. 2004 Jul;48(7):2693-2696. |
|
| 2004-07 |
Drug design for BPR0L075 as an anticancer agent |
Medicine in the 21st Century Tri-Conference & Bio-Forum 2004 Shanghai International Convention Center. 2004 Jul. |
|
| 2004-05-20 |
Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents |
Journal of Medicinal Chemistry. 2004 May;47(11):2897-2905. |
|
| 2003-12-01 |
Substituent effects on di-pi-methane and aza-di-pi-methane rearrangements of dibenzo[f,h]quinoxalinobarrelenes |
Tetrahedron Letters. 2003 Dec;44(49):8761-8764. |
|
| 2003-06-15 |
Dual inhibition of topoisomerase I and tubulin polymerization by BPR0Y007, a novel cytotoxic agent |
Biochemical Pharmacology. 2003 Jun;65(12):2009-2019. |
|
| 2003-03-10 |
Structure-activity and crystallographic analysis of benzophenone derivatives - the potential anticancer agents (vol 13, pg 101, 2003) |
Bioorganic and Medicinal Chemistry Letters. 2003 Mar;13(5):977-977. |
|
| 2003-01-06 |
Structure-activity and crystallographic analysis of benzophenone derivatives - the potential anticancer agents |
Bioorganic and Medicinal Chemistry Letters. 2003 Jan;13(1):101-105. |
|
| 2003 |
The synthetic 1-aroylindoles and 3-aroylindoles derivatives, combretastatin A-4 analogues, as a novel class of potent anticancer agents |
2003 PSROC Annual Meeting. 2003. |
|
| 2002-08 |
Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents |
Abstracts of Papers of the American Chemical Society. 2002 Aug;224:076-MEDI. |
|
| 2002-06-06 |
Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents |
Journal of Medicinal Chemistry. 2002 Jun;45(12):2556-2562. |
|
ORCID:0000-0002-1332-005X6
